Welcome to LookChem.com Sign In|Join Free

CAS

  • or

116574-19-7

Post Buying Request

116574-19-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

116574-19-7 Usage

Type of compound

Cyanoacetate derivative

Structural features

Substituted azetidine ring
Benzhydryl group

Usage

Organic synthesis as a reagent and intermediate

Potential applications

Pharmaceutical research and drug development

Current state of information

Limited detailed information available

Research needs

Further research required to fully understand potential applications and properties

Check Digit Verification of cas no

The CAS Registry Mumber 116574-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,5,7 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 116574-19:
(8*1)+(7*1)+(6*6)+(5*5)+(4*7)+(3*4)+(2*1)+(1*9)=127
127 % 10 = 7
So 116574-19-7 is a valid CAS Registry Number.

116574-19-7Downstream Products

116574-19-7Relevant articles and documents

Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-positions

Kobayashi,Inoue,Nishino,Fujihara,Oizumi,Kimura

, p. 797 - 817 (2007/10/02)

Novel 2-amino-1,4-dihydropyridine derivatives I, which contain N,N-dialkylaminoalkoxycarbonyl groups at the 3- and/or 5-position, were synthesized and their antihypertensive effects were evaluated in spontaneously hypertensive rats. Remarkably prolonged duration of antihypertensive action was observed when a tertiary amino group was introduced into either the 3- or 5-ester side-chain of the 1,4-dihydropyridine ring. In particular, the compounds containing cyclic amino moieties at the 3-position showed greater potency than those with acyclic amino moieties. Chemical modification studies indicated that the two ester side-chains of 1,4-dihydropyridine at the 3- and 5-position might function in a different manner in relation to the antihypertensive activities. 3-(1-Benzhydrylazetidin-3-yl) 5-isopropyl 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxyl ate, I-43 (CS-905), exhibited potent and long-lasting antihypertensive effects with gradual onset of action, and is a promising candidate as an antihypertensive drug.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 116574-19-7